Ethofylline & Theophylline Tablet 77 mg+23mg, 169mg+51mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 77 mg+23mg, 169mg+51mg
Originator reference: - (brand names belong to their owners and are shown only to identify the originator medicine)
Category: Respiratory Disorder
Etofylline+Theophylline is used in the treatment and prevention of chronic obstructive pulmonary disease. Etofylline + Theophylline is a combination of two bronchodilators: Etofylline and Theophylline. They work by relaxing the muscles in the airways and widen the airways. This makes breathing easier.
Manufacture or export Ethofylline & Theophylline Tablet? List it or send an offer →
Product Description:
Etophylline and Theophylline is a combination bronchodilator medication widely used in the management of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and bronchial asthma. This formulation combines two xanthine derivatives that work synergistically to relax the smooth muscles of the airways, leading to bronchodilation and improved airflow to the lungs.
The mechanism of action involves inhibition of phosphodiesterase enzymes, resulting in increased levels of cyclic AMP, which helps reduce bronchial constriction. This leads to relief from symptoms such as wheezing, shortness of breath, chest tightness, and difficulty in breathing. The combination is particularly useful for long-term control and maintenance therapy in patients with chronic respiratory disorders.
Etophylline and Theophylline also improve respiratory function by enhancing diaphragmatic contractility and reducing airway resistance. Due to its effectiveness in providing sustained bronchodilation, it is commonly prescribed in both oral and injectable forms. This makes it a valuable therapeutic option for managing chronic respiratory conditions and improving overall breathing comfort.
Ethofylline & Theophylline Tablet — third party manufacturing & bulk supply
Ethofylline & Theophylline Tablet 77 mg+23mg, 169mg+51mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ethofylline & Theophylline Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ethofylline & Theophylline Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ethofylline & Theophylline Tablet →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Etophylline + Theophylline Tablet is used to treat respiratory conditions such as bronchial asthma, chronic obstructive pulmonary disease (COPD), and bronchospasm. It helps in relaxing airway muscles and improving breathing.
It is made from a combination of Etophylline and Theophylline, which are xanthine derivatives that act as bronchodilators to open up the airways.
The most common trade names include Deriphyllin Tablet and Deriphyllin Retard.
This combination is manufactured by multiple pharmaceutical companies. Other companies make it too, including in India, and we connect buyers with licensed makers that suit their market.
The generic name is Etophylline + Theophylline.
Brand names include Deriphyllin Tablet and Deriphyllin Retard.
This combination is mainly manufactured in India and other Asian countries, which are key suppliers for global export markets.
Related Products
Doxofylline Syrup
Strength:
100 mg/5 ml, 200 mg/5 ml,
Form: Oral Syrup
Originator reference: -
View DetailsBeclomethasone Dipropionate Respiratory Capsule
Strength:
-
Form: Capsules
Originator reference: Qvar (US)
View DetailsTiotropium Bromide
Strength:
1.25 mcg/ actuation & 2.5 mcg/actuation
Form: Soft Mist Inhaler
Originator reference: Spiriva® Respimat®(Eu & US)
View DetailsFormoterol Fumarate /Budesonide
Strength:
DPI: 100 mcg Budesonide / 6 mcg Formoterol, ; MDI: 80 mcg Budesonide / 4.5 mcg Formoterol Fumarate, 160 mcg Budesonide / 4.5 mcg Formoterol Fumarate
Form: Powder For Inhalation(DPI/MDI)
Originator reference: Symbicort®(US); Symbicort® Turbohaler® (EU - various strengths available)
View DetailsLevosalbutamol
Strength:
0.31 mg/3 mL, 0.63 mg/3 mL, and 1.25 mg/3 mL.
Form: Inhalation Solution
Originator reference: Xopenex®(US)
View DetailsFluticasone Propionate
Strength:
0.5 mg/2 mL ampoules, 1 mg/2 mL ampoules
Form: Inhalation suspension for use with nebulizers
Originator reference: Flixotide Nebules(EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit